[Federal Register Volume 78, Number 107 (Tuesday, June 4, 2013)]
[Notices]
[Page 33442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-13217]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application 
Sigma Aldrich Research Biochemicals, Inc.

    Pursuant to 1301.33(a), Title 21 of the Code of Federal Regulations 
(CFR), this is notice that on May 7, 2013, Sigma Aldrich Research 
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-
2447, made application by letter to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone)      I
 (1248).
MDPV (3,4-Methylenedioxypyrovalerone)        I
 (7535).
Methylone (3,4-Methylenedioxy-N-             I
 methylcathinone) (7540).
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 5, 2013.

    Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-13217 Filed 6-3-13; 8:45 am]
BILLING CODE 4410-09-P